Logo image of ALSAF.PA

SAFE ORTHOPAEDICS SA (ALSAF.PA) Stock Fundamental Analysis

EPA:ALSAF - Euronext Paris - Matif - FR001400RKU0 - Common Stock - Currency: EUR

0.0102  +0 (+3.03%)

Fundamental Rating

2

ALSAF gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 55 industry peers in the Health Care Equipment & Supplies industry. ALSAF has a bad profitability rating. Also its financial health evaluation is rather negative. ALSAF is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALSAF has reported negative net income.
ALSAF had negative earnings in each of the past 5 years.
In the past 5 years ALSAF always reported negative operating cash flow.
ALSAF.PA Yearly Net Income VS EBIT VS OCF VS FCFALSAF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

With a Return On Assets value of -342.67%, ALSAF is not doing good in the industry: 92.73% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -342.67%
ROE N/A
ROIC N/A
ROA(3y)-117.06%
ROA(5y)-110.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSAF.PA Yearly ROA, ROE, ROICALSAF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

1.3 Margins

Looking at the Gross Margin, with a value of 74.41%, ALSAF is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
ALSAF's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALSAF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.84%
GM growth 5Y11.39%
ALSAF.PA Yearly Profit, Operating, Gross MarginsALSAF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

More info and screens

0

2. Health

2.1 Basic Checks

ALSAF does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALSAF has more shares outstanding
Compared to 5 years ago, ALSAF has more shares outstanding
The debt/assets ratio for ALSAF is higher compared to a year ago.
ALSAF.PA Yearly Shares OutstandingALSAF.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20K 40K 60K 80K 100K
ALSAF.PA Yearly Total Debt VS Total AssetsALSAF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

ALSAF has an Altman-Z score of -13.66. This is a bad value and indicates that ALSAF is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -13.66, ALSAF is doing worse than 83.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.66
ROIC/WACCN/A
WACC3.68%
ALSAF.PA Yearly LT Debt VS Equity VS FCFALSAF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M -200M

2.3 Liquidity

ALSAF has a Current Ratio of 0.04. This is a bad value and indicates that ALSAF is not financially healthy enough and could expect problems in meeting its short term obligations.
ALSAF's Current ratio of 0.04 is on the low side compared to the rest of the industry. ALSAF is outperformed by 92.73% of its industry peers.
A Quick Ratio of 0.02 indicates that ALSAF may have some problems paying its short term obligations.
ALSAF has a Quick ratio of 0.02. This is amonst the worse of the industry: ALSAF underperforms 92.73% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.02
ALSAF.PA Yearly Current Assets VS Current LiabilitesALSAF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALSAF have decreased by -2.53% in the last year.
The Revenue has decreased by -0.87% in the past year.
Measured over the past years, ALSAF shows a quite strong growth in Revenue. The Revenue has been growing by 10.85% on average per year.
EPS 1Y (TTM)-2.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.87%
Revenue growth 3Y16.67%
Revenue growth 5Y10.85%
Sales Q2Q%N/A

3.2 Future

ALSAF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.47% yearly.
Based on estimates for the next years, ALSAF will show a quite strong growth in Revenue. The Revenue will grow by 15.92% on average per year.
EPS Next Y41.67%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.31%
Revenue Next 2Y15.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSAF.PA Yearly Revenue VS EstimatesALSAF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ALSAF.PA Yearly EPS VS EstimatesALSAF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100M -200M -300M -400M -500M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSAF. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSAF. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSAF.PA Price Earnings VS Forward Price EarningsALSAF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSAF.PA Per share dataALSAF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10K -20K -30K -40K -50K

4.3 Compensation for Growth

A more expensive valuation may be justified as ALSAF's earnings are expected to grow with 22.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALSAF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFE ORTHOPAEDICS SA

EPA:ALSAF (3/7/2025, 7:00:00 PM)

0.0102

+0 (+3.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-22 2024-05-22/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap78.74K
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-54931.55
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.75
BVpS-19.47
TBVpS-19.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -342.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.41%
FCFM N/A
ROA(3y)-117.06%
ROA(5y)-110.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.84%
GM growth 5Y11.39%
F-ScoreN/A
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.02
Altman-Z -13.66
F-ScoreN/A
WACC3.68%
ROIC/WACCN/A
Cap/Depr(3y)105.32%
Cap/Depr(5y)103.66%
Cap/Sales(3y)19.53%
Cap/Sales(5y)16.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y41.67%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.87%
Revenue growth 3Y16.67%
Revenue growth 5Y10.85%
Sales Q2Q%N/A
Revenue Next Year20.31%
Revenue Next 2Y15.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.23%
OCF growth 3YN/A
OCF growth 5YN/A